Literature DB >> 52630

Antigenic variation among parainfluenza type 1 (Sendai) viruses: analysis of 6/94 virus.

F S Lief, W Loh, V T Meulen, H Koprowski.   

Abstract

6/94 virus, isolated originally from a multiple sclerosis (MS) patient, was compared antigenically with related parainfluenza type 1 strains. These included two Sendai strains of mouse and two Sendai strains of reported human origin as well as the HA2 strain. By standard hemagglutination inhibition (HI) or hemadsorption neutralization (HAD-N) tests or by the complement-fixation (CF) cross-block titration test for detecting surface antigens, 6/94 virus and the Sendai virus strains were indistinguishable from each other but distinct from the HA2 strain. By the kinetic HI test, however, 6/94 virus could be readily differentiated from the Sendai viruses isolated from mice and more closely resembled those recovered from man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52630     DOI: 10.1159/000149875

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  4 in total

1.  Pathological alterations of ependyma and choroid plexus after experimental cerebral infection of mice with Sendai virus.

Authors:  G Schwendemann; J Löhler
Journal:  Acta Neuropathol       Date:  1979-04-12       Impact factor: 17.088

2.  Solid phase indirect radioimmunoassay: standardization and applications in viral serology.

Authors:  L L Yung; W Loh; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1977-07-18       Impact factor: 3.402

3.  Persistent parainfluenza type 1 (6/94) infection of brain cells in tissue culture.

Authors:  Z Wroblewska; D Santoli; D Gilden; L Lewandowski; H Koprowski
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Rat tracheal organ culture supports replication of parainfluenza 1 (6/94) virus and promotes 6/94 virus rescue from latently infected human brain cells.

Authors:  Z Wroblewska; M Wellish; L B Rorke; D H Gilden
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.